{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:41:16Z","timestamp":1777290076257,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-023-02195-0","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:02:03Z","timestamp":1694628123000},"page":"2411-2420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The relationship between temporal muscle thickness and disease activity in Cushing\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"given":"D.","family":"Ozaydin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. N.","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Birol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Tanriover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Gazioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-140X","authenticated-orcid":false,"given":"P.","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"issue":"7","key":"2195_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol 4(7):611\u2013629. https:\/\/doi.org\/10.1016\/S2213-8587(16)00086-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9996","key":"2195_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015) Cushing\u2019s syndrome. Lancet 386(9996):913\u2013927. https:\/\/doi.org\/10.1016\/S0140-6736(14)61375-1","journal-title":"Lancet"},{"issue":"12","key":"2195_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2195_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/er.2013-1048","volume":"36","author":"R Pivonello","year":"2015","unstructured":"Pivonello R, De Leo M, Cozzolino A, Colao A (2015) The Treatment of Cushing\u2019s Disease. Endocr Rev 36(4):385\u2013486. https:\/\/doi.org\/10.1210\/er.2013-1048","journal-title":"Endocr Rev"},{"key":"2195_CR5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3389\/fendo.2020.00648","volume":"11","author":"R Pivonello","year":"2020","unstructured":"Pivonello R, Ferrigno R, De Martino MC et al (2020) Medical treatment of cushing\u2019s disease: an overview of the current and recent clinical trials. Front Endocrinol (Lausanne) 11:648. https:\/\/doi.org\/10.3389\/fendo.2020.00648","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2195_CR6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fendo.2019.00766","volume":"10","author":"LT Braun","year":"2019","unstructured":"Braun LT, Riester A, O\u00dfwald-Kopp A et al (2019) Toward a diagnostic score in cushing\u2019s syndrome. Front Endocrinol (Lausanne) 10:766. https:\/\/doi.org\/10.3389\/fendo.2019.00766","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2195_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1530\/EJE-16-0689","volume":"176","author":"CM Berr","year":"2017","unstructured":"Berr CM, Stieg MR, Deutschbein T et al (2017) Persistence of myopathy in Cushing\u2019s syndrome: evaluation of the German Cushing\u2019s registry. Eur J Endocrinol 176(6):737\u2013746. https:\/\/doi.org\/10.1530\/EJE-16-0689","journal-title":"Eur J Endocrinol"},{"issue":"7396","key":"2195_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11083","volume":"485","author":"CC Thoreen","year":"2012","unstructured":"Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485(7396):109\u2013113. https:\/\/doi.org\/10.1038\/nature11083","journal-title":"Nature"},{"issue":"1","key":"2195_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1096\/fj.03-0610com","volume":"18","author":"SH Lecker","year":"2004","unstructured":"Lecker SH, Jagoe RT, Gilbert A et al (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18(1):39\u201351. https:\/\/doi.org\/10.1096\/fj.03-0610com","journal-title":"FASEB J"},{"issue":"7","key":"2195_CR10","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1681\/ASN.2006010083","volume":"17","author":"SH Lecker","year":"2006","unstructured":"Lecker SH, Goldberg AL, Mitch WE (2006) Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 17(7):1807\u20131819. https:\/\/doi.org\/10.1681\/ASN.2006010083","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2195_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1042\/bj2060641","volume":"206","author":"JA McGrath","year":"1982","unstructured":"McGrath JA, Goldspink DF (1982) Glucocorticoid action on protein synthesis and protein breakdown in isolated skeletal muscles. Biochem J 206(3):641\u2013645. https:\/\/doi.org\/10.1042\/bj2060641","journal-title":"Biochem J"},{"issue":"3","key":"2195_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1079\/bjn19980047","volume":"79","author":"I Savary","year":"1998","unstructured":"Savary I, Debras E, Dardevet D et al (1998) Effect of glucocorticoid excess on skeletal muscle and heart protein synthesis in adult and old rats. Br J Nutr 79(3):297\u2013304. https:\/\/doi.org\/10.1079\/bjn19980047","journal-title":"Br J Nutr"},{"issue":"1","key":"2195_CR13","doi-asserted-by":"publisher","first-page":"e16674","DOI":"10.1371\/journal.pone.0016674","volume":"6","author":"K Biedasek","year":"2011","unstructured":"Biedasek K, Andres J, Mai K et al (2011) Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1. PLoS One 6(1):e16674. https:\/\/doi.org\/10.1371\/journal.pone.0016674","journal-title":"PLoS One"},{"issue":"6","key":"2195_CR14","doi-asserted-by":"publisher","first-page":"E495","DOI":"10.1152\/ajpendo.00389.2016","volume":"312","author":"SH Kang","year":"2017","unstructured":"Kang SH, Lee HA, Kim M, Lee E, Sohn UD, Kim I (2017) Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing\u2019s syndrome. Am J Physiol Endocrinol Metab 312(6):E495\u2013E507. https:\/\/doi.org\/10.1152\/ajpendo.00389.2016","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"2195_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1530\/JOE-16-0011","volume":"229","author":"SA Morgan","year":"2016","unstructured":"Morgan SA, Hassan-Smith ZK, Doig CL, Sherlock M, Stewart PM, Lavery GG (2016) Glucocorticoids and 11\u03b2-HSD1 are major regulators of intramyocellular protein metabolism. J Endocrinol 229(3):277\u2013286. https:\/\/doi.org\/10.1530\/JOE-16-0011","journal-title":"J Endocrinol"},{"key":"2195_CR16","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2018.2.14","author":"M Canepari","year":"2018","unstructured":"Canepari M, Agoni V, Brocca L et al (2018) Structural and molecular adaptations to dexamethasone and unacylated ghrelin administration in skeletal muscle of the mice. J Physiol Pharmacol. https:\/\/doi.org\/10.26402\/jpp.2018.2.14","journal-title":"J Physiol Pharmacol"},{"issue":"6","key":"2195_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/mus.880170625","volume":"17","author":"E Olafsson","year":"1994","unstructured":"Olafsson E, Jones HR Jr, Guay AT, Thomas CB (1994) Myopathy of endogenous Cushing\u2019s syndrome: a review of the clinical and electromyographic features in 8 patients. Muscle Nerve 17(6):692\u2013693. https:\/\/doi.org\/10.1002\/mus.880170625","journal-title":"Muscle Nerve"},{"issue":"2","key":"2195_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2265.1983.tb03198.x","volume":"18","author":"AA Khaleeli","year":"1983","unstructured":"Khaleeli AA, Edwards RH, Gohil K et al (1983) Corticosteroid myopathy: a clinical and pathological study. Clin Endocrinol (Oxf) 18(2):155\u2013166. https:\/\/doi.org\/10.1111\/j.1365-2265.1983.tb03198.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2195_CR19","doi-asserted-by":"publisher","first-page":"e4490","DOI":"10.1210\/clinem\/dgaa625","volume":"105","author":"F Vogel","year":"2020","unstructured":"Vogel F, Braun LT, Rubinstein G et al (2020) Persisting muscle dysfunction in cushing\u2019s syndrome despite biochemical remission. J Clin Endocrinol Metab 105(12):e4490\u2013e4498. https:\/\/doi.org\/10.1210\/clinem\/dgaa625","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2195_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/07435800.2018.1461904","volume":"43","author":"MA Minetto","year":"2018","unstructured":"Minetto MA, Caresio C, D\u2019Angelo V et al (2018) Diagnostic evaluation in steroid-induced myopathy: case report suggesting clinical utility of quantitative muscle ultrasonography. Endocr Res 43(4):235\u2013245. https:\/\/doi.org\/10.1080\/07435800.2018.1461904","journal-title":"Endocr Res"},{"issue":"1","key":"2195_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"issue":"11","key":"2195_CR22","doi-asserted-by":"publisher","first-page":"e0207849","DOI":"10.1371\/journal.pone.0207849","volume":"13","author":"J Leitner","year":"2018","unstructured":"Leitner J, Pelster S, Sch\u00f6pf V et al (2018) High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases. PLoS One 13(11):e0207849. https:\/\/doi.org\/10.1371\/journal.pone.0207849","journal-title":"PLoS One"},{"issue":"5","key":"2195_CR23","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3390\/jcm9051272","volume":"9","author":"A Steindl","year":"2020","unstructured":"Steindl A, Leitner J, Schwarz M et al (2020) Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength Evaluation. J Clin Med 9(5):1272. https:\/\/doi.org\/10.3390\/jcm9051272","journal-title":"J Clin Med"},{"issue":"1","key":"2195_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12877-021-02086-0","volume":"21","author":"Y Hasegawa","year":"2021","unstructured":"Hasegawa Y, Yoshida M, Sato A et al (2021) A change in temporal muscle thickness is correlated with past energy adequacy in bedridden older adults: a prospective cohort study. BMC Geriatr 21(1):182. https:\/\/doi.org\/10.1186\/s12877-021-02086-0","journal-title":"BMC Geriatr"},{"issue":"2","key":"2195_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/ggi.13570","volume":"19","author":"Y Hasegawa","year":"2019","unstructured":"Hasegawa Y, Yoshida M, Sato A et al (2019) Temporal muscle thickness as a new indicator of nutritional status in older individuals. Geriatr Gerontol Int 19(2):135\u2013140. https:\/\/doi.org\/10.1111\/ggi.13570","journal-title":"Geriatr Gerontol Int"},{"issue":"8","key":"2195_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13137","volume":"34","author":"AR Hayes","year":"2022","unstructured":"Hayes AR, Grossman AB (2022) Distinguishing Cushing\u2019s disease from the ectopic ACTH syndrome: needles in a haystack or hiding in plain sight? J Neuroendocrinol 34(8):e13137","journal-title":"J Neuroendocrinol"},{"key":"2195_CR27","doi-asserted-by":"publisher","first-page":"523292","DOI":"10.3389\/fneur.2020.523292","volume":"11","author":"F Liu","year":"2020","unstructured":"Liu F, Xing D, Zha Y et al (2020) Predictive value of temporal muscle thickness measurements on cranial magnetic resonance \u0131mages in the prognosis of patients with primary glioblastoma. Front Neurol 11:523292. https:\/\/doi.org\/10.3389\/fneur.2020.523292","journal-title":"Front Neurol"},{"key":"2195_CR28","doi-asserted-by":"publisher","first-page":"104439","DOI":"10.1016\/j.archger.2021.104439","volume":"96","author":"K Sakai","year":"2021","unstructured":"Sakai K, Katayama M, Nakajima J et al (2021) Temporal muscle thickness is associated with the severity of dysphagia in patients with acute stroke. Arch Gerontol Geriatr 96:104439. https:\/\/doi.org\/10.1016\/j.archger.2021.104439","journal-title":"Arch Gerontol Geriatr"},{"key":"2195_CR29","doi-asserted-by":"publisher","first-page":"106444","DOI":"10.1016\/j.clineuro.2020.106444","volume":"201","author":"M Nozoe","year":"2021","unstructured":"Nozoe M, Kubo H, Kanai M et al (2021) Reliability and validity of measuring temporal muscle thickness as the evaluation of sarcopenia risk and the relationship with functional outcome in older patients with acute stroke. Clin Neurol Neurosurg 201:106444. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106444","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"2195_CR30","doi-asserted-by":"publisher","first-page":"106173","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106173","volume":"31","author":"GGC Gomes","year":"2022","unstructured":"Gomes GGC, Palinkas M, da Silva GP et al (2022) Bite force, thickness, and thermographic patterns of masticatory muscles post-hemorrhagic stroke. J Stroke Cerebrovasc Dis 31(1):106173. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.106173","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"8","key":"2195_CR31","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1007\/s00330-016-4707-6","volume":"27","author":"J Furtner","year":"2017","unstructured":"Furtner J, Berghoff AS, Albtoush OM et al (2017) Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases. Eur Radiol 27(8):3167\u20133173. https:\/\/doi.org\/10.1007\/s00330-016-4707-6","journal-title":"Eur Radiol"},{"issue":"1","key":"2195_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-018-2948-8","volume":"140","author":"J Furtner","year":"2018","unstructured":"Furtner J, Berghoff AS, Sch\u00f6pf V et al (2018) Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases. J Neurooncol 140(1):173\u2013178. https:\/\/doi.org\/10.1007\/s11060-018-2948-8","journal-title":"J Neurooncol"},{"issue":"1\u20133","key":"2195_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsbmb.2009.05.014","volume":"117","author":"AJ Dirks-Naylor","year":"2009","unstructured":"Dirks-Naylor AJ, Griffiths CL (2009) Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy. J Steroid Biochem Mol Biol 117(1\u20133):1\u20137. https:\/\/doi.org\/10.1016\/j.jsbmb.2009.05.014","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"2195_CR34","doi-asserted-by":"publisher","first-page":"e1477","DOI":"10.1210\/clinem\/dgab862","volume":"107","author":"S Katsuhara","year":"2022","unstructured":"Katsuhara S, Yokomoto-Umakoshi M, Umakoshi H et al (2022) Impact of cortisol on reduction in muscle strength and mass: a mendelian randomization study. J Clin Endocrinol Metab 107(4):e1477\u2013e1487. https:\/\/doi.org\/10.1210\/clinem\/dgab862","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2195_CR35","doi-asserted-by":"publisher","first-page":"dgz29","DOI":"10.1210\/clinem\/dgz329","volume":"105","author":"L Martel-Duguech","year":"2020","unstructured":"Martel-Duguech L, Alonso-Jim\u00e9nez A, Bascu\u00f1ana H et al (2020) Thigh muscle fat \u0131nfiltration \u0131s associated with \u0131mpaired physical performance despite remission in cushing\u2019s syndrome. J Clin Endocrinol Metab 105(5):dgz29. https:\/\/doi.org\/10.1210\/clinem\/dgz329","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2195_CR36","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1210\/jcem.87.3.8321","volume":"87","author":"M Pirlich","year":"2002","unstructured":"Pirlich M, Biering H, Gerl H et al (2002) Loss of body cell mass in Cushing\u2019s syndrome: effect of treatment. J Clin Endocrinol Metab 87(3):1078\u20131084. https:\/\/doi.org\/10.1210\/jcem.87.3.8321","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02195-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02195-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02195-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T01:11:13Z","timestamp":1696641073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02195-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["2195"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02195-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]},"assertion":[{"value":"30 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or nonfinancial interests and declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study conformed to the ethical principles for medical research with human participants as described in the Declaration of Helsinki of the World Medical Association. The Ethics Committee of Istanbul University-Cerrahpa\u015fa approved the study (approval number: 711070).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Signed informed consent was obtained from all study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}